CASCELLA ROBERT 4

What Happened Robert Cascella, a director of KORU Medical Systems, received a grant/award of 3,571 shares on July 1, 2026. The per-share value reported in the Form 4 is $4.20, for a total acquisition value of $14,998. This transaction is coded as an award/acquisition (code A), i.e., issuance of shares rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-01; Price per share: $4.20; Total value: $14,998.
• Transaction type: Award/Grant (SEC code A).
• Shares owned after the transaction: Not reported in this Form 4.
• Filing status: Form 4 filed same day (no late filing indicated).
• Remarks on the filing: Includes a disclaimer that the filer does not admit beneficial ownership for Section 16 purposes and notes a Power of Attorney was previously filed.

Context Grants or awards to directors are commonly part of compensation or director equity plans; they represent an acquisition of shares but do not necessarily indicate trading intent. The reported amount ($~15k) is relatively modest compared with large insider trades; retail investors should view this as routine director compensation unless further material filings follow.